Results 51 to 60 of about 30,144 (233)
Exergy and Economic Analysis of Hybrid Mechanical Vapor Compression and Membrane Distillation
ABSTRACT Hybridization of two or more desalination processes has been identified as an attractive option for improved energy efficiency and recovery rate. To appropriately assess the performance enhancement of hybrid desalination systems, an integrated approach for energy, exergy, economic, and environmental investigations should be adopted. This study
Emad Ali, Jamel Orfi
wiley +1 more source
Small and mid‐sized pharmaceutical innovators often have limited in‐house health economics and market access expertise, and may struggle to align development strategies of investigational medicinal products with health system needs and payer expectations.
Zoltán Kaló +5 more
wiley +1 more source
Maria Kamusheva, 1 Desislava Ignatova, 2 Anna Golda, 3 Agnieszka Skowron 3 1Department of “Organization and Economics of Pharmacy”, Faculty of Pharmacy, Medical University of Sofia, Sofia, Bulgaria; 2Department of “Psychiatry and ...
Kamusheva M +3 more
doaj
Early‐stage health technology assessment of a curative gene therapy for multiple sclerosis
Aims Multiple sclerosis (MS) is associated with significant early morbidity, reduced life expectancy and substantial healthcare and societal costs. The primary objective of this study is to assess the early cost‐effectiveness potential of a novel gene therapy, IMMUTOL, for MS compared with current high‐efficacy treatment sequences.
Attila Imre, Balázs Nagy, Rok Hren
wiley +1 more source
Cost–benefit analysis of screening programme for diabetic retinopathy in Bulgaria
Aims Late‐diagnosed diabetic retinopathy (DR) is difficult and expensive to treat. Screening programmes can identify the disease early and reduce the costs of its future treatment. This study aims to analyse the cost–benefit of screening programmes for DR.
Iva Nenkova +5 more
wiley +1 more source
Is the Brazilian pharmaceutical policy ensuring population access to essential medicines?
Background To evaluate medicine prices, availability and affordability in Brazil, considering the differences across three types of medicines (originator brands, generics and similar medicines) and different types of facilities (private pharmacies ...
Bertoldi Andréa +4 more
doaj +1 more source
Aims Predetermined treatment duration limits (PTDLs) are often used by Taiwan's National Health Insurance Administration to contain healthcare costs, but they may compromise patient outcomes. Therefore, we studied Taiwan's 2017 extension of the bevacizumab PTDL from 24 to 36 weeks in metastatic colorectal cancer (mCRC) to evaluate whether prolonged ...
Wei‐Ming Huang +6 more
wiley +1 more source
Feedback is the most powerful driver of learning, but it can afford variable effects depending on the method used. The design of feedback for computer‐based assessment—now increasingly prevalent in higher education—remains relatively underexplored, particularly for pharmacology education.
Claire Y. Hepburn
wiley +1 more source
Objectives This study addresses the growing importance of health economics and pharmacoeconomics in preparing healthcare professionals for economic decision-making, particularly in China’s evolving healthcare system.
Jian Yang +5 more
doaj +1 more source
Background: In public health emergencies, such as the COVID-19 pandemic, the work strategies of clinical pharmacists need to be modified according to the rapid spread of the disease, where information and resources are constantly changing.
Omid Barati +6 more
doaj

